Search

David P Steensma

from Lincoln, MA
Age ~54
Get Report
Also known as:
David Peter Steensma, Peter D Steensma, Peter S Steensma, Dave Steensma, David A
Related to:
Evan Karlsteensma Ream, 42
Connected to:
Ben A Steensma, 80Erin K Steensma, 62Frank H Steensnaes, 55Ken A Steensland, 55Kyle M Steenson, 57Nancy S Steenson, 76Robin Steenson, 55Timothy L Steenson, 74Eric T Steenstra, 58George R Steenton, 67

David Steensma Phones & Addresses

  • Lincoln, MA
  • 122 Great Plain Ave, Wellesley, MA 02482 (781) 237-1036
  • 607 5Th St, Rochester, MN 55902 (507) 252-1781
  • 8566 Hibma Rd, Marion, MI 49665
  • Chicago, IL
  • Haledon, NJ

Work

Company: Department of Medical Oncology Address: 450 Brookline Ave, Boston, MA 02215

Education

School / High School: University Of Chicago/The Pritzker School Of Medicine 1996

Languages

English

Awards

Healthgrades Honor Roll • Fellowship, American College of Physicia...

Ranks

Certificate: Hematology, 2002

Images

Specialities

Hematology • Medical Oncology • Oncology

Professional Records

Medicine Doctors

David Steensma Photo 1

Dr. David P Steensma, Boston MA - MD (Doctor of Medicine)

View page
Specialties:
Hematology
Medical Oncology
Oncology
Address:
Department of Medical Oncology
450 Brookline Ave, Boston, MA 02215

Mayo Clinic
200 1St St Sw, Rochester, MN 55905
(507) 284-2511 (Phone)
Procedures:
Bone Marrow Disorders
Chemotherapeutic Agents
Chemotherapy
Hematologic Malignancies
Conditions:
Acute Lymphoblastic Leukemia, Adult
Acute Megacaryoblastic Leukemia
Acute Myeloblastic Leukemia Type 1
Acute Myeloblastic Leukemia Type 2
Acute Myeloblastic Leukemia Type 3
Acute Myeloblastic Leukemia Type 4
Acute Myeloblastic Leukemia Type 5
Acute Myeloblastic Leukemia Type 6
Acute Myeloblastic Leukemia Type 7
Acute Myelocytic Leukemia
Acute Myelofibrosis
Aplastic Anemia-Paroxysmal Nocturnal Hemoglobinuria Syndrome
Chemotherapy
Chronic Myeloid Leukemia
Chronic Myelomonocytic Leukemia
Chronic Myeloproliferative Disorders
Hematologic Malignancies
Myelodysplastic Syndrome
Myelodysplastic Syndrome (Pre-Leukemia)
Myelodysplastic Syndrome Associated With Isolated Del(5q) Chromosome Abnormality
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Disease
Myelofibrosis
Myeloproliferative Diseases
Myeloproliferative Disorders
Polycythemia
Polycythemia Rubra
Polycythemia Vera
Sideroblastic Anemia
Sideroblastic Anemia, Autosomal
Sideroblastic Anemia, Hereditary
Sideroblastic Anemia, Pyridoxine-Responsive, Autosomal Recessive
Certifications:
Hematology, 2002
Internal Medicine, 2009
Medical Oncology, 2003
Awards:
Healthgrades Honor Roll
Fellowship, American College of Physicians, 2005
Languages:
English
Hospitals:
Department of Medical Oncology
450 Brookline Ave, Boston, MA 02215

Mayo Clinic
200 1St St Sw, Rochester, MN 55905

Brigham and Women's Hospital
75 Francis Street, Boston, MA 02115
Education:
Medical School
University Of Chicago/The Pritzker School Of Medicine
Graduated: 1996
Medical School
Mayo Clinic
Graduated: 1997
Medical School
Mayo Clinic
Graduated: 1999
Medical School
Mayo Clinic
Graduated: 2002
Medical School
University Of Oxford, Weatherall Institute Of Molecular Medicine
Graduated: 2004
David Steensma Photo 2

David P. Steensma

View page
Specialties:
Hematology/Oncology
Education:
Medical School
University of Chicago Pritzker School of Medicine
Graduated: 1996
Procedures:
Bone Marrow Biopsy
Vaccine Administration
Chemotherapy
Electrocardiogram (EKG or ECG)
Conditions:
Anemia
Acute Renal Failure
Anxiety Phobic Disorders
Atrial Fibrillation and Atrial Flutter
Autism
Description:
Dr. Steensma graduated from the University of Chicago Pritzker School of Medicine in 1996. He works in Boston, MA and specializes in Hematology/Oncology. Dr. Steensma is affiliated with Boston Childrens Hospital, Brigham & Womens Hospital and MassGeneral For Children At North Shore Medical Center.
David Steensma Photo 3

David P Steensma, Boston MA

View page
Specialties:
Internal Medicine
Hematology & Oncology
Hematology
Medical Oncology
Work:
Dana-Farber Cancer Institute
450 Brookline Ave, Boston, MA 02215
Critical Care & Respiratory
200 1St St SW, Rochester, MN 55905
Dana-Farber Cancer Institute
44 Binney St, Boston, MA 02115
Education:
University of Chicago (1996)

Business Records

Name / Title
Company / Classification
Phones & Addresses
David Peter Steensma
David Steensma MD
Internist
200 1 St SW, Rochester, MN 55905
(507) 284-2511

Publications

Amazon

Myelodysplastic Syndromes: Pathobiology And Clinical Management (Basic And Clinical Oncology)

Myelodysplastic Syndromes: Pathobiology and Clinical Management (Basic and Clinical Oncology)

View page

Written by a team of leading authorities in pathogenesis, diagnostic techniques, and clinical management strategies in myelodysplastic syndrome (MDS), this text provides a concise, easy-to-follow review of the advances in the science, classification, diagnosis, and management of the condition. An ...
Binding

Hardcover

Pages

536

Publisher

CRC Press

ISBN #

1420074393

EAN Code

9781420074390

ISBN #

1

Quick-Reaction Report on Base Closure and Realignment Budget Data for the Naval Station Puget Sound (Sand Point), Washington

View page
Author

David K. Steensma

Binding

Paperback

Publisher

PN

ISBN #

10

Comprehensive Long-Term Environmental Action, Navy Contract

View page
Author

David K. Steensma

Binding

Paperback

Publisher

PN

ISBN #

9

Quick-Reaction Report on Base Realignment Budget Data for Naval Station,Philadelphia, and Naval Training Center, Great Lakes

View page
Author

David K. Steensma

Binding

Paperback

Publisher

PN

ISBN #

8

DOD Rental of Defense National Stockpile Center Facilities

View page
Author

David K. Steensma

Binding

Paperback

Publisher

PN

ISBN #

7

Environmental Compliance Assessment Programs

View page
Author

David K. Steensma

Binding

Paperback

Publisher

PN

ISBN #

6

DoD Leasing of Family Housing

View page
Author

David K. Steensma

Binding

Paperback

Publisher

PN

ISBN #

5

DoD Procurements from Federal Prison Industries

View page
Author

David K. Steensma

Binding

Paperback

Publisher

PN

ISBN #

4

Us Patents

Erythropoietic Stimulating Agent (Esa) Dosage Determination

View page
US Patent:
20130191097, Jul 25, 2013
Filed:
Jan 4, 2011
Appl. No.:
13/519843
Inventors:
Craig L. Hocum - Winona MN, US
James T. McCarthy - Rochester MN, US
David P. Steensma - Wellesley MA, US
David Dingli - Rochester MN, US
James L. Rogers - Rochester MN, US
Edward J. Gallaher - Hillsboro OR, US
Assignee:
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH - Rochester MN
International Classification:
G06F 19/12
US Classification:
703 11
Abstract:
An Erythropoietic Stimulating Agent (ESA) dosing system/method determines patient-specific ESA therapies for patients affected by insufficient hemoglobin production that may benefit from ESA treatment. The ESA dosing system includes a model that represents a process by which red blood cells are produced in humans. The model may include one or more parameters, the values of which are patient-specific. The model takes into account patient-specific historical hemoglobin (Hgb) data and corresponding historical ESA dosage data to estimate the patient-specific values of the model parameters, and determines a target therapeutic dose of the ESA that may maintain the patient's Hgb within a target range.

Erythropoietic Stimulating Agent (Esa) Dosage Determination

View page
US Patent:
20180218110, Aug 2, 2018
Filed:
Mar 22, 2018
Appl. No.:
15/928717
Inventors:
- Rochester MN, US
James T. McCarthy - Rochester MN, US
David P. Steensma - Wellesley MA, US
David Dingli - Rochester MN, US
Edward J. Gallaher - Hillsboro OR, US
James L. Rogers - Rochester MN, US
International Classification:
G06F 19/12
Abstract:
An Erythropoietic Stimulating Agent (ESA) dosing system/method determines patient-specific ESA therapies for patients affected by insufficient hemoglobin production that may benefit from ESA treatment. The ESA dosing system includes a model that represents a process by which red blood cells are produced in humans. The model may include one or more parameters, the values of which are patient-specific. The model takes into account patient-specific historical hemoglobin (Hgb) data and corresponding historical ESA dosage data to estimate the patient-specific values of the model parameters, and determines a target therapeutic dose of the ESA that may maintain the patient's Hgb within a target range.
Control profile
David P Steensma from Lincoln, MA, age ~54 Get Report